Skip to main content
. 2021 Mar 29;60(17):2831–2837. doi: 10.2169/internalmedicine.6470-20

Figure 2.

Figure 2.

Clinical course and duration of steroid therapy and its temporary efficacy against IgG4-related disease (IgG4-RD). Serum IgG4 and interleukin-2 receptor levels remarkably improved during the administration of steroids and increased after the discontinuation of steroids, along with gradual enlargement in the tumor mass in the right lower lobe of the lung.